カテゴリ： Market Monitor Global, 世界, 医療/バイオ

僧帽弁介入のグローバル市場展望 2023年-2029年：置換製品、再建製品、弁輪製品

■ 英語タイトル：Mitral Valve Intervention Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23JU5305）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23JU5305
■ 発行日：2023年6月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：120
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥474,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥616,850見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥711,750見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[僧帽弁介入のグローバル市場展望 2023年-2029年：置換製品、再建製品、弁輪製品]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の僧帽弁介入市場規模と予測を収録しています。・世界の僧帽弁介入市場：売上、2018年-2023年、2024年-2029年
・世界の僧帽弁介入市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の僧帽弁介入市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「置換製品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

僧帽弁介入のグローバル主要企業は、Edwards Lifesciences、 Abbott、 CardioSolution、 NeoChord、 Mitralign、 Medtronic、 Boston Scientific、 Mitralix、 Shanghai Hanyu Medical Technology、 Valgen Holding Corporation、 NeoChord、 CoreMedic、 Babic Chord、 Gore Medical、 Valtech Cardio、 Transcardiac、 ChoRe、 AVVIE、 Cardiovalve、 HighLife SAS、 Neovasc、 MitrAssist Lifesciences、 Shanghai NewMed Medical、 Peijia Medical、 MicroPort CardioFlow Medtechなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、僧帽弁介入のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の僧帽弁介入市場：タイプ別、2018年-2023年、2024年-2029年
世界の僧帽弁介入市場：タイプ別市場シェア、2022年
・置換製品、再建製品、弁輪製品

世界の僧帽弁介入市場：用途別、2018年-2023年、2024年-2029年
世界の僧帽弁介入市場：用途別市場シェア、2022年
・経心尖部、ストック経由・間質経由、右内頚静脈

世界の僧帽弁介入市場：地域・国別、2018年-2023年、2024年-2029年
世界の僧帽弁介入市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における僧帽弁介入のグローバル売上、2018年-2023年
・主要企業における僧帽弁介入のグローバル売上シェア、2022年
・主要企業における僧帽弁介入のグローバル販売量、2018年-2023年
・主要企業における僧帽弁介入のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Edwards Lifesciences、 Abbott、 CardioSolution、 NeoChord、 Mitralign、 Medtronic、 Boston Scientific、 Mitralix、 Shanghai Hanyu Medical Technology、 Valgen Holding Corporation、 NeoChord、 CoreMedic、 Babic Chord、 Gore Medical、 Valtech Cardio、 Transcardiac、 ChoRe、 AVVIE、 Cardiovalve、 HighLife SAS、 Neovasc、 MitrAssist Lifesciences、 Shanghai NewMed Medical、 Peijia Medical、 MicroPort CardioFlow Medtech

*************************************************************

・調査・分析レポートの概要
僧帽弁介入市場の定義
市場セグメント
世界の僧帽弁介入市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の僧帽弁介入市場規模
世界の僧帽弁介入市場規模：2022年 VS 2029年
世界の僧帽弁介入市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの僧帽弁介入の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の僧帽弁介入製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：置換製品、再建製品、弁輪製品
僧帽弁介入のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：経心尖部、ストック経由・間質経由、右内頚静脈
僧帽弁介入の用途別グローバル売上・予測

・地域別市場分析
地域別僧帽弁介入市場規模 2022年と2029年
地域別僧帽弁介入売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Edwards Lifesciences、 Abbott、 CardioSolution、 NeoChord、 Mitralign、 Medtronic、 Boston Scientific、 Mitralix、 Shanghai Hanyu Medical Technology、 Valgen Holding Corporation、 NeoChord、 CoreMedic、 Babic Chord、 Gore Medical、 Valtech Cardio、 Transcardiac、 ChoRe、 AVVIE、 Cardiovalve、 HighLife SAS、 Neovasc、 MitrAssist Lifesciences、 Shanghai NewMed Medical、 Peijia Medical、 MicroPort CardioFlow Medtech
...

The mitral valve is composed of the mitral valve annulus, mitral valve leaflets, chordae tendineae and papillary muscles. One part of the mitral valve leaflet including the anterior and posterior leaflets is connected to the mitral valve annulus, and the other end is connected to the chordae tendineae, while the chordae tendineae is connected to the mitral valve annulus. It is connected to the papillary muscle and constitutes the structural integrity of the mitral valve. The integrity of mitral valve function requires that the size of the mitral valve annulus is appropriate, the valve leaflet structure is complete, the papillary muscles contract and stretch the chordae tendineae to support the valve leaflets, the left ventricular muscle contraction produces appropriate closing force, and the ventricular morphology and function are normal.
This report aims to provide a comprehensive presentation of the global market for Mitral Valve Intervention, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mitral Valve Intervention. This report contains market size and forecasts of Mitral Valve Intervention in global, including the following market information:
Global Mitral Valve Intervention Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Mitral Valve Intervention Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Mitral Valve Intervention companies in 2022 (%)
The global Mitral Valve Intervention market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Replacement Product Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Mitral Valve Intervention include Edwards Lifesciences, Abbott, CardioSolution, NeoChord, Mitralign, Medtronic, Boston Scientific, Mitralix and Shanghai Hanyu Medical Technology, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mitral Valve Intervention manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mitral Valve Intervention Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Mitral Valve Intervention Market Segment Percentages, by Type, 2022 (%)
Replacement Product
Repair Product
Annulus Products
Global Mitral Valve Intervention Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Mitral Valve Intervention Market Segment Percentages, by Application, 2022 (%)
Transapical
Via Stock and Via Interstitial
Right Internal Jugular Vein
Global Mitral Valve Intervention Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Mitral Valve Intervention Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mitral Valve Intervention revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Mitral Valve Intervention revenues share in global market, 2022 (%)
Key companies Mitral Valve Intervention sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Mitral Valve Intervention sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Edwards Lifesciences
Abbott
CardioSolution
NeoChord
Mitralign
Medtronic
Boston Scientific
Mitralix
Shanghai Hanyu Medical Technology
Valgen Holding Corporation
NeoChord
CoreMedic
Babic Chord
Gore Medical
Valtech Cardio
Transcardiac
ChoRe
AVVIE
Cardiovalve
HighLife SAS
Neovasc
MitrAssist Lifesciences
Shanghai NewMed Medical
Peijia Medical
MicroPort CardioFlow Medtech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Mitral Valve Intervention, market overview.
Chapter 2: Global Mitral Valve Intervention market size in revenue and volume.
Chapter 3: Detailed analysis of Mitral Valve Intervention manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mitral Valve Intervention in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Mitral Valve Intervention capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Mitral Valve Intervention Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mitral Valve Intervention Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mitral Valve Intervention Overall Market Size
2.1 Global Mitral Valve Intervention Market Size: 2022 VS 2029
2.2 Global Mitral Valve Intervention Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Mitral Valve Intervention Sales: 2018-2029
3 Company Landscape
3.1 Top Mitral Valve Intervention Players in Global Market
3.2 Top Global Mitral Valve Intervention Companies Ranked by Revenue
3.3 Global Mitral Valve Intervention Revenue by Companies
3.4 Global Mitral Valve Intervention Sales by Companies
3.5 Global Mitral Valve Intervention Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Mitral Valve Intervention Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Mitral Valve Intervention Product Type
3.8 Tier 1, Tier 2 and Tier 3 Mitral Valve Intervention Players in Global Market
3.8.1 List of Global Tier 1 Mitral Valve Intervention Companies
3.8.2 List of Global Tier 2 and Tier 3 Mitral Valve Intervention Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Mitral Valve Intervention Market Size Markets, 2022 & 2029
4.1.2 Replacement Product
4.1.3 Repair Product
4.1.4 Annulus Products
4.2 By Type – Global Mitral Valve Intervention Revenue & Forecasts
4.2.1 By Type – Global Mitral Valve Intervention Revenue, 2018-2023
4.2.2 By Type – Global Mitral Valve Intervention Revenue, 2024-2029
4.2.3 By Type – Global Mitral Valve Intervention Revenue Market Share, 2018-2029
4.3 By Type – Global Mitral Valve Intervention Sales & Forecasts
4.3.1 By Type – Global Mitral Valve Intervention Sales, 2018-2023
4.3.2 By Type – Global Mitral Valve Intervention Sales, 2024-2029
4.3.3 By Type – Global Mitral Valve Intervention Sales Market Share, 2018-2029
4.4 By Type – Global Mitral Valve Intervention Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Mitral Valve Intervention Market Size, 2022 & 2029
5.1.2 Transapical
5.1.3 Via Stock and Via Interstitial
5.1.4 Right Internal Jugular Vein
5.2 By Application – Global Mitral Valve Intervention Revenue & Forecasts
5.2.1 By Application – Global Mitral Valve Intervention Revenue, 2018-2023
5.2.2 By Application – Global Mitral Valve Intervention Revenue, 2024-2029
5.2.3 By Application – Global Mitral Valve Intervention Revenue Market Share, 2018-2029
5.3 By Application – Global Mitral Valve Intervention Sales & Forecasts
5.3.1 By Application – Global Mitral Valve Intervention Sales, 2018-2023
5.3.2 By Application – Global Mitral Valve Intervention Sales, 2024-2029
5.3.3 By Application – Global Mitral Valve Intervention Sales Market Share, 2018-2029
5.4 By Application – Global Mitral Valve Intervention Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Mitral Valve Intervention Market Size, 2022 & 2029
6.2 By Region – Global Mitral Valve Intervention Revenue & Forecasts
6.2.1 By Region – Global Mitral Valve Intervention Revenue, 2018-2023
6.2.2 By Region – Global Mitral Valve Intervention Revenue, 2024-2029
6.2.3 By Region – Global Mitral Valve Intervention Revenue Market Share, 2018-2029
6.3 By Region – Global Mitral Valve Intervention Sales & Forecasts
6.3.1 By Region – Global Mitral Valve Intervention Sales, 2018-2023
6.3.2 By Region – Global Mitral Valve Intervention Sales, 2024-2029
6.3.3 By Region – Global Mitral Valve Intervention Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Mitral Valve Intervention Revenue, 2018-2029
6.4.2 By Country – North America Mitral Valve Intervention Sales, 2018-2029
6.4.3 US Mitral Valve Intervention Market Size, 2018-2029
6.4.4 Canada Mitral Valve Intervention Market Size, 2018-2029
6.4.5 Mexico Mitral Valve Intervention Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Mitral Valve Intervention Revenue, 2018-2029
6.5.2 By Country – Europe Mitral Valve Intervention Sales, 2018-2029
6.5.3 Germany Mitral Valve Intervention Market Size, 2018-2029
6.5.4 France Mitral Valve Intervention Market Size, 2018-2029
6.5.5 U.K. Mitral Valve Intervention Market Size, 2018-2029
6.5.6 Italy Mitral Valve Intervention Market Size, 2018-2029
6.5.7 Russia Mitral Valve Intervention Market Size, 2018-2029
6.5.8 Nordic Countries Mitral Valve Intervention Market Size, 2018-2029
6.5.9 Benelux Mitral Valve Intervention Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Mitral Valve Intervention Revenue, 2018-2029
6.6.2 By Region – Asia Mitral Valve Intervention Sales, 2018-2029
6.6.3 China Mitral Valve Intervention Market Size, 2018-2029
6.6.4 Japan Mitral Valve Intervention Market Size, 2018-2029
6.6.5 South Korea Mitral Valve Intervention Market Size, 2018-2029
6.6.6 Southeast Asia Mitral Valve Intervention Market Size, 2018-2029
6.6.7 India Mitral Valve Intervention Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Mitral Valve Intervention Revenue, 2018-2029
6.7.2 By Country – South America Mitral Valve Intervention Sales, 2018-2029
6.7.3 Brazil Mitral Valve Intervention Market Size, 2018-2029
6.7.4 Argentina Mitral Valve Intervention Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Mitral Valve Intervention Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Mitral Valve Intervention Sales, 2018-2029
6.8.3 Turkey Mitral Valve Intervention Market Size, 2018-2029
6.8.4 Israel Mitral Valve Intervention Market Size, 2018-2029
6.8.5 Saudi Arabia Mitral Valve Intervention Market Size, 2018-2029
6.8.6 UAE Mitral Valve Intervention Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Edwards Lifesciences
7.1.1 Edwards Lifesciences Company Summary
7.1.2 Edwards Lifesciences Business Overview
7.1.3 Edwards Lifesciences Mitral Valve Intervention Major Product Offerings
7.1.4 Edwards Lifesciences Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.1.5 Edwards Lifesciences Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Mitral Valve Intervention Major Product Offerings
7.2.4 Abbott Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 CardioSolution
7.3.1 CardioSolution Company Summary
7.3.2 CardioSolution Business Overview
7.3.3 CardioSolution Mitral Valve Intervention Major Product Offerings
7.3.4 CardioSolution Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.3.5 CardioSolution Key News & Latest Developments
7.4 NeoChord
7.4.1 NeoChord Company Summary
7.4.2 NeoChord Business Overview
7.4.3 NeoChord Mitral Valve Intervention Major Product Offerings
7.4.4 NeoChord Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.4.5 NeoChord Key News & Latest Developments
7.5 Mitralign
7.5.1 Mitralign Company Summary
7.5.2 Mitralign Business Overview
7.5.3 Mitralign Mitral Valve Intervention Major Product Offerings
7.5.4 Mitralign Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.5.5 Mitralign Key News & Latest Developments
7.6 Medtronic
7.6.1 Medtronic Company Summary
7.6.2 Medtronic Business Overview
7.6.3 Medtronic Mitral Valve Intervention Major Product Offerings
7.6.4 Medtronic Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.6.5 Medtronic Key News & Latest Developments
7.7 Boston Scientific
7.7.1 Boston Scientific Company Summary
7.7.2 Boston Scientific Business Overview
7.7.3 Boston Scientific Mitral Valve Intervention Major Product Offerings
7.7.4 Boston Scientific Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.7.5 Boston Scientific Key News & Latest Developments
7.8 Mitralix
7.8.1 Mitralix Company Summary
7.8.2 Mitralix Business Overview
7.8.3 Mitralix Mitral Valve Intervention Major Product Offerings
7.8.4 Mitralix Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.8.5 Mitralix Key News & Latest Developments
7.9 Shanghai Hanyu Medical Technology
7.9.1 Shanghai Hanyu Medical Technology Company Summary
7.9.2 Shanghai Hanyu Medical Technology Business Overview
7.9.3 Shanghai Hanyu Medical Technology Mitral Valve Intervention Major Product Offerings
7.9.4 Shanghai Hanyu Medical Technology Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.9.5 Shanghai Hanyu Medical Technology Key News & Latest Developments
7.10 Valgen Holding Corporation
7.10.1 Valgen Holding Corporation Company Summary
7.10.2 Valgen Holding Corporation Business Overview
7.10.3 Valgen Holding Corporation Mitral Valve Intervention Major Product Offerings
7.10.4 Valgen Holding Corporation Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.10.5 Valgen Holding Corporation Key News & Latest Developments
7.11 NeoChord
7.11.1 NeoChord Company Summary
7.11.2 NeoChord Mitral Valve Intervention Business Overview
7.11.3 NeoChord Mitral Valve Intervention Major Product Offerings
7.11.4 NeoChord Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.11.5 NeoChord Key News & Latest Developments
7.12 CoreMedic
7.12.1 CoreMedic Company Summary
7.12.2 CoreMedic Mitral Valve Intervention Business Overview
7.12.3 CoreMedic Mitral Valve Intervention Major Product Offerings
7.12.4 CoreMedic Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.12.5 CoreMedic Key News & Latest Developments
7.13 Babic Chord
7.13.1 Babic Chord Company Summary
7.13.2 Babic Chord Mitral Valve Intervention Business Overview
7.13.3 Babic Chord Mitral Valve Intervention Major Product Offerings
7.13.4 Babic Chord Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.13.5 Babic Chord Key News & Latest Developments
7.14 Gore Medical
7.14.1 Gore Medical Company Summary
7.14.2 Gore Medical Business Overview
7.14.3 Gore Medical Mitral Valve Intervention Major Product Offerings
7.14.4 Gore Medical Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.14.5 Gore Medical Key News & Latest Developments
7.15 Valtech Cardio
7.15.1 Valtech Cardio Company Summary
7.15.2 Valtech Cardio Business Overview
7.15.3 Valtech Cardio Mitral Valve Intervention Major Product Offerings
7.15.4 Valtech Cardio Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.15.5 Valtech Cardio Key News & Latest Developments
7.16 Transcardiac
7.16.1 Transcardiac Company Summary
7.16.2 Transcardiac Business Overview
7.16.3 Transcardiac Mitral Valve Intervention Major Product Offerings
7.16.4 Transcardiac Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.16.5 Transcardiac Key News & Latest Developments
7.17 ChoRe
7.17.1 ChoRe Company Summary
7.17.2 ChoRe Business Overview
7.17.3 ChoRe Mitral Valve Intervention Major Product Offerings
7.17.4 ChoRe Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.17.5 ChoRe Key News & Latest Developments
7.18 AVVIE
7.18.1 AVVIE Company Summary
7.18.2 AVVIE Business Overview
7.18.3 AVVIE Mitral Valve Intervention Major Product Offerings
7.18.4 AVVIE Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.18.5 AVVIE Key News & Latest Developments
7.19 Cardiovalve
7.19.1 Cardiovalve Company Summary
7.19.2 Cardiovalve Business Overview
7.19.3 Cardiovalve Mitral Valve Intervention Major Product Offerings
7.19.4 Cardiovalve Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.19.5 Cardiovalve Key News & Latest Developments
7.20 HighLife SAS
7.20.1 HighLife SAS Company Summary
7.20.2 HighLife SAS Business Overview
7.20.3 HighLife SAS Mitral Valve Intervention Major Product Offerings
7.20.4 HighLife SAS Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.20.5 HighLife SAS Key News & Latest Developments
7.21 Neovasc
7.21.1 Neovasc Company Summary
7.21.2 Neovasc Business Overview
7.21.3 Neovasc Mitral Valve Intervention Major Product Offerings
7.21.4 Neovasc Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.21.5 Neovasc Key News & Latest Developments
7.22 MitrAssist Lifesciences
7.22.1 MitrAssist Lifesciences Company Summary
7.22.2 MitrAssist Lifesciences Business Overview
7.22.3 MitrAssist Lifesciences Mitral Valve Intervention Major Product Offerings
7.22.4 MitrAssist Lifesciences Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.22.5 MitrAssist Lifesciences Key News & Latest Developments
7.23 Shanghai NewMed Medical
7.23.1 Shanghai NewMed Medical Company Summary
7.23.2 Shanghai NewMed Medical Business Overview
7.23.3 Shanghai NewMed Medical Mitral Valve Intervention Major Product Offerings
7.23.4 Shanghai NewMed Medical Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.23.5 Shanghai NewMed Medical Key News & Latest Developments
7.24 Peijia Medical
7.24.1 Peijia Medical Company Summary
7.24.2 Peijia Medical Business Overview
7.24.3 Peijia Medical Mitral Valve Intervention Major Product Offerings
7.24.4 Peijia Medical Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.24.5 Peijia Medical Key News & Latest Developments
7.25 MicroPort CardioFlow Medtech
7.25.1 MicroPort CardioFlow Medtech Company Summary
7.25.2 MicroPort CardioFlow Medtech Business Overview
7.25.3 MicroPort CardioFlow Medtech Mitral Valve Intervention Major Product Offerings
7.25.4 MicroPort CardioFlow Medtech Mitral Valve Intervention Sales and Revenue in Global (2018-2023)
7.25.5 MicroPort CardioFlow Medtech Key News & Latest Developments
8 Global Mitral Valve Intervention Production Capacity, Analysis
8.1 Global Mitral Valve Intervention Production Capacity, 2018-2029
8.2 Mitral Valve Intervention Production Capacity of Key Manufacturers in Global Market
8.3 Global Mitral Valve Intervention Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Mitral Valve Intervention Supply Chain Analysis
10.1 Mitral Valve Intervention Industry Value Chain
10.2 Mitral Valve Intervention Upstream Market
10.3 Mitral Valve Intervention Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Mitral Valve Intervention Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 経皮的冠動脈インターベンション用バルーンカテーテルのグローバル市場展望 2023年-2029年：セミコンプライアント、ノンコンプライアント、コンプライアント
  • 人工弁のグローバル市場展望 2023年-2029年：経カテーテルバルブ、ティッシュバルブ、メカニカルバルブ
  • 人工心臓弁のグローバル市場展望 2023年-2029年：経カテーテル心臓弁、組織心臓弁、機械式心臓弁
  • 心臓弁プロテーゼのグローバル市場展望 2023年-2029年：経カテーテル心臓弁、組織心臓弁、機械式心臓弁
  • 心臓弁置換装置のグローバル市場展望 2023年-2029年：機械式、組織、経カテーテル
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23JU5305 )"僧帽弁介入のグローバル市場展望 2023年-2029年：置換製品、再建製品、弁輪製品" (英文：Mitral Valve Intervention Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。